Inotuzumab Ozogamicin
Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).
Year introduced: 2020 (2004)
PubMed search builder options
Subheadings:
Tree Number(s): D09.408.051.247.750, D12.776.124.486.485.114.224.060.794, D12.776.124.790.651.114.224.060.794, D12.776.377.715.548.114.224.200.794
MeSH Unique ID: D000080045
Registry Number: P93RUU11P7
Entry Terms:
- CMC544
- CMC-544
- CMC 544
- Besponsa
Pharmacologic Action: